HSV-2
HSV-2: Discover advancements in treatment, including FDA-approved Hovilpri for antiviral-resistant herpes, impacting management in immunocompromised adults.
![FDA Approves Hovilpri for Herpes Lesions Resistant to Antiviral Treatment in Immunocompromised Adults]()
FDA Approves Hovilpri for Herpes Lesions Resistant to Antiviral Treatment in Immunocompromised Adults
Published on 10/10/2026
